NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)

The summary for the NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01): Purpose. This Funding Opportunity Announcement (FOA), issued by the NIAMS, National Institutes of Health, solicits applications for research awards designed to develop and evaluate new clinical trial outcomes measures to assess the adverse events, and the link between efficacy and effectiveness of therapies employed to treat diseases, illnesses and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and initial evaluation of new clinically-relevant and patient-important outcome measures and instruments that could be further tested with existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, treatment or cure of diseases, illnesses and injuries of interest to the NIAMS. Mechanism of Support. This FOA will utilize the U01 cooperative agreement grant mechanism. Funds Available and Anticipated Number of Awards. The NIAMS intends to commit approximately $1.0 million in FY 2010 to fund four or five new grants in response to this FOA. These awards are not renewable.

Federal Grant Title:	NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AR-10-005
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.846
CFDA Descriptions:	Arthritis, Musculoskeletal and Skin Diseases Research
Current Application Deadline:	Aug 31, 2009
Original Application Deadline:	Aug 31, 2009
Posted Date:	Apr 17, 2009
Creation Date:	Apr 17, 2009
Archive Date:	Oct 01, 2009
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:	$150,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...; • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...; • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...; • Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed); • NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed); • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa); • Niams Small Grant Program for New Investigators; • Skin Diseases Research Core Centers
More Grants from the National Institutes of Health: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)